ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk

December 13, 2002

NCI Breast Tissue Registry Available To Researchers

March 24, 1995